Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01517529 · ClinicalTrials.gov registry record
Evaluating the Role of Immune Responses in the Emergence of Protease Inhibitor Mutations
A clinical trial, sponsored by University of Cincinnati.
- Completed
- Registry status
- 10
- Enrollment target
NCT01517529: Completed study, sponsored by University of Cincinnati.
NCT01517529 is a clinical trial that has completed, run by University of Cincinnati. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01517529 has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The major goal of this project is to identify the role of the immune responses in the emergence of protease inhibitor mutants during therapy.
Primary Outcome
Blood samples will be drawn while the subject is on treatment to measure viral load and HCV-specific immune responses.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2012-01 |
| Est. Completion | 2014-12 |
What the finished NCT01517529 record still lists
NCT01517529 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01517529 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01517529 about?
NCT01517529 is a clinical study titled "Evaluating the Role of Immune Responses in the Emergence of Protease Inhibitor Mutations". The major goal of this project is to identify the role of the immune responses in the emergence of protease inhibitor mutants during therapy.
What is the current status of trial NCT01517529?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2012-01. Estimated completion is 2014-12.
Who is sponsoring clinical trial NCT01517529?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia